Citation 90407

WANG,N: YAO,XS: ISHII,R: KITANAKA,S:. (2003). BIOACTIVE SUCROSE ESTERS FROM BIDENS PARVIFLORA.. 62(5)

Citation Details

Title	BIOACTIVE SUCROSE ESTERS FROM BIDENS PARVIFLORA.
Authors	WANG,N: YAO,XS: ISHII,R: KITANAKA,S:
Year	2003
Volume	62
Issue	5

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Bidens parviflora (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GLYCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUTOFURANOSYL(2-1):	None
2	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUTOFURANOSYL(2-1):	ACTIVE
3	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUTOFURANOSYL(2-1):	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GLUCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUCTOFURANOSYL(2-1)-(6-O-TRANS-PARA-COUMAROYL):	None
5	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUCTOFURANOSYL(2-1)-(6-O-TRANS-PARA-COUMAROYL):	INACTIVE
6	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOPYRANOSIDE,ALPHA-D: (6-O-TRANS-PARA-COUMAROYL)-BETA-D-FRUCTOFURANOSYL(2-1)-(6-O-TRANS-PARA-COUMAROYL):	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CYCLOBUTANE-1-2-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-BETA-4-BETA-BIS-(4-HYDROXY-PHENYL):	None
8	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOBUTANE-1-2-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-BETA-4-BETA-BIS-(4-HYDROXY-PHENYL):	INACTIVE
9	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOBUTANE-1-2-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-BETA-4-BETA-BIS-(4-HYDROXY-PHENYL):	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CYCLOBUTANE-1-3-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-ALPHA-4-ALPHA-BIS-(3-4-DIHYDROXY-PHENYL):	None
11	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOBUTANE-1-3-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-ALPHA-4-ALPHA-BIS-(3-4-DIHYDROXY-PHENYL):	ACTIVE
12	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOBUTANE-1-3-DICARBOXYLIC ACID,1-ALPHA-2-ALPHA-3-ALPHA-4-ALPHA-BIS-(3-4-DIHYDROXY-PHENYL):	ACTIVE

Show SPARQL Queries (1)